XML 38 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2022
Summary of Significant Accounting Policies [Abstract]  
Schedule of Revenue by Source Generated from Services The following sets forth the revenue by source generated from services provided by the Company:
   2022   2021 
Epigenetic biomarker services  $400   $
-
 
Epigenetic biomarker royalties   83    85 
Life insurance commissions   28    35 
Total revenue  $511   $120